← Back to all studies
gut microbiome diet

A Systematic Review of Folate and the Human Enteric Microbiome: Biological Mechanisms and Clinical Implications

3 June 2026

Khanduja R, Frye RE.

Summary

What the study found

This research reveals a complex, two-way relationship where the gut microbiome acts as both a producer and a consumer of folate (vitamin B9). While most gut bacteria cannot make their own folate, a small group of beneficial microbes provides this essential nutrient to the rest of the community, influencing human DNA repair, immune function, and disease risk.

Key findings

  • Only a minority of bacteria, specifically prototrophic taxa like Bifidobacterium and Lactobacillus, possess the full genetic machinery to synthesize folate from scratch.
  • Dysregulation of microbial folate pathways is linked to genomic instability and impaired methylation, which are foundational drivers of cardiovascular, neurological, and oncologic disorders.
  • Targeted probiotic interventions currently offer the highest level of clinical evidence for successfully modulating the folate-microbiome axis in humans.
  • The interaction between host genetics and the microbiome suggests that one-carbon metabolism is highly individualized, meaning different people respond uniquely to folate sources.

Practical takeaways

To optimize your folate status for longevity, prioritize a diet that supports "cross-feeding" bacteria, particularly through fermented foods or probiotics containing Bifidobacterium and Lactobacillus species. Since individual gut profiles and genetics dictate how folate is processed, personalized nutrition approaches may be more effective than generic high-dose supplementation.

Limitations

The majority of current data is derived from animal models or observational studies, which can identify patterns but cannot confirm that microbial changes directly cause health outcomes. There is a significant need for large-scale human clinical trials to establish definitive guidelines for folate-related microbiome therapy.

Abstract

Folate (vitamin B9) is central to one-carbon metabolism, supporting nucleotide biosynthesis, methylation homeostasis, and epigenetic regulation. The gut microbiome both produces and consumes folate, creating a bidirectional axis influencing host health and disease. We systematically reviewed 159 original studies from MEDLINE, Google Scholar, Embase, and Scopus (inception through January 2026) examining enteric microbiota-folate interactions, with intervention evidence graded using the Oxford Centre for Evidence-Based Medicine 2011 framework. Only a minority of gut bacteria possess complete folate biosynthetic pathways; most depend on cross-feeding from prototrophic taxa including <i>Bifidobacterium</i>, <i>Lactobacillus</i>, and <i>Streptococcus</i>. Altered microbial folate metabolism was associated with metabolic, gastrointestinal, oncologic, neuropsychiatric, cardiovascular, immunologic, and reproductive disorders through convergent mechanisms of disrupted methylation, genomic instability, and immune dysregulation. Probiotic interventions achieved the strongest evidence, supported by multiple human controlled and observational trials and animal models. The evidence for prebiotic, dietary, and folate supplementation interventions was moderate due to the predominant animal models and in vitro data. Overall, the predominant associational and observational evidence base is insufficient to establish causal relationships, underscoring the need for adequately powered human randomized controlled trials with folate-specific endpoints, multi-omics integration, and precision approaches matching folate form and dose to individual microbiome and host genetic profiles.
Source study →